Searchable abstracts of presentations at key conferences in endocrinology

ea0055wd7 | Workshop D: Disorders of the thyroid gland (II) | SFEEU2018

A challenging case of progressive follicular thyroid cancer

Hussain Shazia , Brennan Carmel , Plowman Nick , Newbold Kate , Drake William

A 60 year old gentleman with a history of renal stones presented 5 years ago with left sided flank pain. A CT of his renal tract showed an unexpected metastatic deposit in the left iliac crest. Cross-sectional whole body imaging, performed to locate the primary, also identified an expansile soft tissue mass in the T8 vertebral body and a predominantly cystic looking left sided thyroid nodule. He proceeded to have an iliac crest biopsy which was consistent with metastatic folli...

ea0031p358 | Thyroid | SFEBES2013

Prevalence of anti-thyroglobulin antibodies, their prognostic significance and impact on patient care in a cohort of patients with differentiated thyroid cancer

O'Toole Sam , Pittaway James , Raja Omair , Buckland Matthew , Plowman Nick , Brennan Carmel , Waterhouse Mona , Akker Scott , Drake Will , Druce Maralyn

Background: The measurement of thyroglobulin (Tg) is important in the follow-up of patients with differentiated thyroid cancer (DTC), but interpretation is subject to interference by anti-thyroglobulin antibodies (TgAb). National guidelines recommend measurement of TgAb status but no consensus exists on how surveillance should be adapted in cases of TgAb positivity.Aims: To evaluate the impact of TgAbs on clinical management, in a single-centre cohort of...

ea0050p401 | Thyroid | SFEBES2017

Does presence of ‘Coexisting Thyroiditis’ affect Radioiodine Uptake in Thyroid Cancer Ablation Doses?

Shah Shanty George , Waterhouse Mona , Akker Scott , Drake William , Plowman Nick , Berney Daniel M , Richards Polly , Adams Ashok , Nowosinska Ewa , Brennan Carmel , Druce Maralyn

Background: Patients being treated for differentiated thyroid cancer (DTC) receive a dose of Radioiodine for remnant ablation. Occasional patients appear to have little or no iodine uptake at all in the thyroid bed or else where even shortly after thyroidectomy.Objective: To evaluate the influence of ‘Coexisting Thyroiditis’ on radioiodine uptake in thyroid cancer ablation doses.Methods and Design: Retrospec...

ea0050p401 | Thyroid | SFEBES2017

Does presence of ‘Coexisting Thyroiditis’ affect Radioiodine Uptake in Thyroid Cancer Ablation Doses?

Shah Shanty George , Waterhouse Mona , Akker Scott , Drake William , Plowman Nick , Berney Daniel M , Richards Polly , Adams Ashok , Nowosinska Ewa , Brennan Carmel , Druce Maralyn

Background: Patients being treated for differentiated thyroid cancer (DTC) receive a dose of Radioiodine for remnant ablation. Occasional patients appear to have little or no iodine uptake at all in the thyroid bed or else where even shortly after thyroidectomy.Objective: To evaluate the influence of ‘Coexisting Thyroiditis’ on radioiodine uptake in thyroid cancer ablation doses.Methods and Design: Retrospec...